CRM vs PLTR: Which Is the Better Buy?

Side-by-side comparison of Salesforce, Inc. and Palantir Technologies Inc. — fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-05-07.
Salesforce, Inc. · Technology
$182.14
+45.0% upside to fair value
Grade B High Quality
VS
Palantir Technologies Inc. · Technology
$133.79
-41.7% upside to fair value
Grade C High Quality
QuantHub Verdict
CRM has more upside to fair value (+45.0%). CRM trades at a lower forward P/E (22.8x). These are model outputs — not personalized investment advice. See all research →
Valuation & Fundamentals
Metric CRM PLTR
Current Price $182.14 $133.79
Fair Value Estimate $264.10 $78.04
Upside to Fair Value +45.0% -41.7%
Market Cap $173.0B $306.6B
Forward P/E 22.8x 140.4x
EV / EBITDA 14.4x 151.4x
Price / Sales 4.2x 58.7x
Price / FCF 12.0x 114.0x
Revenue Growth YoY +12.1% +84.7%
Gross Margin 77.7% 84.1%
Operating Margin 21.5% 38.1%
Return on Equity 12.4% 32.2%
Dividend Yield 0% 0%
FCF Yield 8.33% 0.88%
Analyst Consensus Buy Buy
Investment Thesis
CRM — Salesforce, Inc.
Salesforce, Inc. is a leading enterprise software company specializing in cloud-based customer relationship management and enterprise applications. The company benefits from a durable competitive moat anchored by pioneering SaaS delivery, a large and growing customer base, and a diversified revenue mix with Service Cloud as the largest segment generating $9.05 billion in FY2025. Salesforce exhibi…
PLTR — Palantir Technologies Inc.
Palantir Technologies Inc. is a high-growth enterprise software company specializing in data analytics and intelligence platforms for government and commercial clients. The company benefits from a durable competitive moat through its established government contracts, proprietary platforms Gotham and Foundry, and expanding commercial footprint. Palantir's revenue grew 84.7% year-over-year in the m…
Accumulation Zones
Metric CRM PLTR
Zone Low $198.08 $58.53
Zone High $224.49 $66.33
In Buy Zone? Yes No
← CRM Research    PLTR Research →    All Research